Zynerba Pharmaceuticals, Inc. Restricted Stock Award Agreement under 2023 Stock Option and Incentive Plan
This agreement is between Zynerba Pharmaceuticals, Inc. and an individual grantee, granting the grantee restricted shares of company stock under the 2023 Stock Option and Incentive Plan. The shares are subject to vesting conditions and cannot be sold or transferred until vested. If the grantee's service with the company ends before vesting, the unvested shares are forfeited. The agreement also covers tax withholding, data privacy, and other standard terms. The grantee receives dividends and voting rights on the shares while they are restricted.
Exhibit 10.5
RESTRICTED STOCK AWARD AGREEMENT
UNDER THE ZYNERBA PHARMACEUTICALS, INC.
2023 STOCK OPTION AND INCENTIVE PLAN
Name of Grantee:
No. of Shares:
Grant Date:
Pursuant to the Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, Zynerba Pharmaceuticals, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan. The Company acknowledges the receipt from the Grantee of consideration with respect to the par value of the Stock in the form of cash, past or future services rendered to the Company by the Grantee or such other form of consideration as is acceptable to the Administrator.
ACTIVE ###-###-####.8
Incremental Number | Vesting Date |
_____________ (___%) | ____________ |
_____________ (___%) | ____________ |
_____________ (___%) | ____________ |
_____________ (___%) | ____________ |
_____________ (___%) | ____________ |
Subsequent to such Vesting Date or Dates, the shares of Stock on which all restrictions and conditions have lapsed shall no longer be deemed Restricted Stock. The Administrator may at any time accelerate the vesting schedule specified in this Section 3.
2
ACTIVE ###-###-####.8
3
ACTIVE ###-###-####.8
ZYNERBA PHARMACEUTICALS, INC.
By:
Title:
The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.
Dated:
Grantee’s Signature
Grantee’s name and address:
4
ACTIVE ###-###-####.8